Genetic Testing Company | The DNA Diagnostic Experts | GeneDx

Usher Syndrome Panel

FORMS AND DOCUMENTS

TEST DETAILS

Genes:
CDH23, CLRN1, DFNB31 (WHRN), GPR98, MYO7A, PCDH15, USH1C, USH1G, USH2A
Disorders:
Clinical Utility:
  • Confirmation of a clinical diagnosis
  • Recurrence risk assessment
  • Prenatal diagnosis
Lab Method:
Next-gen Sequencing

ORDERING

Test Code:
585
Turnaround Time:
8-9 weeks
Preferred Specimen:
2-5 mL Blood - Lavender Top Tube

BILLING

CPT Codes:
81404x1, 81407x1, 81408x1
New York Approved:
No
ABN Required:
Yes
Billing Information:
View Billing Policy
ICD Codes:
  • 362.74: Pigmentary retinal dystrophy, Retinal dystrophy, albipunctate, Retinitis pigmentosa
  • 389.1: Sensorineural hearing loss, Perceptive hearing loss or deafness
  • 362.76: Dystrophies primarily involving the retinal pigment epithelium, Fundus flavimaculatus, Vitelliform dystrophy
  • 362.75: Other dystrophies
* For price inquiries please email zebras@genedx.com

REFERENCES

  1. Saihan et al., (2009) Curr Opin Neurol 22:19-27
  2. Yan et al., (2010) Journal of Human Genetics 55:327-335
  3. Millan et al. (2011) Journal of Ophthalmology Volume 2011:1-8
  4. Adato et al (2002) Eur J Hum Genet 10:339-350
  5. Bitner-Glindzicz et al., (2000) Nat Genet 26:56-60
  6. Roux et al., (2006) J Med Genet 43:763-768
  7. Adato et al., (1997) Am J Hum Genet 61:813-821
  8. Hilgert et al., (2009) J Hum Med Genet 46:272-276
  9. Bennett S et al., (2004) Pharmacogenomics 5:433-8
  10. Pieke Dahl S et al., (1996 ) J Med Genet 33:753-7
  11. Weston et al., 2000 Am J Hum Genet 66:1199-210
  12. van Wijk et al., (2004) Am J Hum Genet 74:738-744; 13
  13. Aller et al., 2010 Invest Ophthalmol and Vis Sci 51(11):5480-5485
  14. Roux AF et al., (2011) Invest Ophthalmol Vis Sci. 8;52(7):4063-71
  15. Besnard T (2012) Hum Mutat 33(3):504-10

Back To Top